Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...

Speculation is mounting that Johnson & Johnson could buy its Danish R&D partner Genmab, a pairing that has created the successful blood cancer drug Darzalex. J&J this year bought Swiss biotech ...